Market Overview:
The global surgical tumor ablation market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing incidence of cancer, technological advancements in surgical tumor ablation devices, and rising demand for minimally invasive surgeries. Based on type, the global surgical tumor ablation market is segmented into radiofrequency ablation (RFA), microwave ablation (MWA), cryoablation, and others. RFA held the largest share of the global surgical tumor ablation market in 2017 owing to its high efficacy and safety profile. MWA is expected to be the fastest-growing segment during the forecast period due to its ability to achieve complete lesion destruction with low thermal injury. Based on application, the global surgical tumor ablation market is segmented into liver cancer, breast cancer, lung cancer, prostate cancer, and others. Liver cancer held a major share of the global surgical tumor ablations market in 2017 due to high incidence rates worldwide coupled with growing awareness about early diagnosis and treatment options for liver cancers.
Product Definition:
Surgical tumor ablation is the surgical removal of a tumor. The importance of surgical tumor ablation is that it can remove a tumor before it has the chance to grow and spread.
Radiofrequency Ablation:
Radiofrequency Ablation (RFA) is a minimally invasive surgical procedure used to treat tumors. It uses electromagnetic energy to destroy the tissue that covers the tumor and leaves healthy tissues unaffected. The process is commonly used for prostate, kidney, breast, head & neck and other types of tumors.
Microwave Ablation:
microwave ablation is a surgical procedure that uses very high power microwave radiations to destroy tissues and cells without affecting the surrounding areas. The process is used for the treatment of various conditions such as tumors, lesions, vascular disorders & skin tags. It also helps in shrinking these target tissues down to an almost imperceptible size so that they can be removed by the body's immune system.
Application Insights:
The breast cancer segment held the largest share of the global surgical tumor ablation market in 2017. This can be attributed to increasing prevalence rates of breast cancer and technological advancements in surgical tumor ablation procedures that have led to an increase in its use for treating this disease. For instance, Cryo-TK¢â‚¬â„¢s procedure is used for treating liver tumors and has been approved by the U.S FDA (Food & Drug Administration) for this purpose only.
Lung cancer is expected to be one of the fastest growing segments over the forecast period due to factors such as population growth, tobacco smoking habits and high incidence rates globally which are likely to result in a significant rise during future years too.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of industry players, high adoption rate of technologically advanced procedures, and availability of reimbursement coverage. The region is expected to maintain its dominance throughout the forecast period owing to increasing cases of cancer and growing preference for minimally invasive surgeries over open surgeries.
Asia Pacific is anticipated to witness lucrative growth during the forecast period due to factors such as rising medical tourism, improving healthcare infrastructure & affordability along with an increase in awareness about available treatments for various cancers & diseases. In addition, government initiatives are also being taken up by regional companies for distribution across countries so that patients have access better treatment options at lesser costs (Ex: Microwave Ablation Technique Market By Region). These initiatives help reduce procedural volumes while maintaining quality standards which benefits both hospitals as well as patients alike (Ex: Cryoablation Procedure Market Size By Hospital Type).
Growth Factors:
- Increasing incidence of cancer: The global incidence of cancer is increasing at an alarming rate. This is expected to drive the demand for surgical tumor ablation procedures in the coming years.
- Growing awareness about surgical tumor ablation: There is a growing awareness among people about the benefits of surgical tumor ablation procedures. This is likely to boost the demand for these procedures in the near future.
- Technological advancements: The technological advancements in surgical tumor ablation are helping to improve patient outcomes and reduce complications associated with these procedures. This is likely to propel the growth of this market in the coming years.
- Rising healthcare expenditure: The rising healthcare expenditure worldwide is providing a major impetus to the growth of various medical devices and therapies, including surgical tumor ablation market .This trend is expected to continue in the foreseeable future, thereby propelling market growth during this period.. 5)Growing number of surgeons trained in performing Surgical Tumor Ablations-The number if surgeons who are proficient at performing Surgical Tumor Ablations continues grow each year as more physicians seek specialized training courses on how best perform these minimally invasive ablative techniques
Scope Of The Report
Report Attributes
Report Details
Report Title
Surgical Tumor Ablation Market Research Report
By Type
Radiofrequency Ablation, Microwave Ablation, Cryoablation, Others
By Application
Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Others
By Companies
Galil Medical, Misonix, HealthTronics, AngioDynamics, Medtronic, Boston Scientific Corporation, Medtronic, SonaCare Medical, EDAP TMS, NeuWave Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
179
Number of Tables & Figures
126
Customization Available
Yes, the report can be customized as per your need.
Global Surgical Tumor Ablation Market Report Segments:
The global Surgical Tumor Ablation market is segmented on the basis of:
Types
Radiofrequency Ablation, Microwave Ablation, Cryoablation, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Galil Medical
- Misonix
- HealthTronics
- AngioDynamics
- Medtronic
- Boston Scientific Corporation
- Medtronic
- SonaCare Medical
- EDAP TMS
- NeuWave Medical
Highlights of The Surgical Tumor Ablation Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Radiofrequency Ablation
- Microwave Ablation
- Cryoablation
- Others
- By Application:
- Liver Cancer
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Surgical Tumor Ablation Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Surgical tumor ablation is a type of cancer treatment that uses heat and radiation to destroy tumors.
Some of the key players operating in the surgical tumor ablation market are Galil Medical, Misonix, HealthTronics, AngioDynamics, Medtronic, Boston Scientific Corporation, Medtronic, SonaCare Medical, EDAP TMS, NeuWave Medical.
The surgical tumor ablation market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Surgical Tumor Ablation Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Surgical Tumor Ablation Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Surgical Tumor Ablation Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Surgical Tumor Ablation Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Surgical Tumor Ablation Market Size & Forecast, 2018-2028
4.5.1 Surgical Tumor Ablation Market Size and Y-o-Y Growth
4.5.2 Surgical Tumor Ablation Market Absolute $ Opportunity
Chapter 5 Global Surgical Tumor Ablation Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Surgical Tumor Ablation Market Size Forecast by Type
5.2.1 Radiofrequency Ablation
5.2.2 Microwave Ablation
5.2.3 Cryoablation
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Surgical Tumor Ablation Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Surgical Tumor Ablation Market Size Forecast by Applications
6.2.1 Liver Cancer
6.2.2 Breast Cancer
6.2.3 Lung Cancer
6.2.4 Prostate Cancer
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Surgical Tumor Ablation Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Surgical Tumor Ablation Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Surgical Tumor Ablation Analysis and Forecast
9.1 Introduction
9.2 North America Surgical Tumor Ablation Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Surgical Tumor Ablation Market Size Forecast by Type
9.6.1 Radiofrequency Ablation
9.6.2 Microwave Ablation
9.6.3 Cryoablation
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Surgical Tumor Ablation Market Size Forecast by Applications
9.10.1 Liver Cancer
9.10.2 Breast Cancer
9.10.3 Lung Cancer
9.10.4 Prostate Cancer
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Surgical Tumor Ablation Analysis and Forecast
10.1 Introduction
10.2 Europe Surgical Tumor Ablation Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Surgical Tumor Ablation Market Size Forecast by Type
10.6.1 Radiofrequency Ablation
10.6.2 Microwave Ablation
10.6.3 Cryoablation
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Surgical Tumor Ablation Market Size Forecast by Applications
10.10.1 Liver Cancer
10.10.2 Breast Cancer
10.10.3 Lung Cancer
10.10.4 Prostate Cancer
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Surgical Tumor Ablation Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Surgical Tumor Ablation Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Surgical Tumor Ablation Market Size Forecast by Type
11.6.1 Radiofrequency Ablation
11.6.2 Microwave Ablation
11.6.3 Cryoablation
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Surgical Tumor Ablation Market Size Forecast by Applications
11.10.1 Liver Cancer
11.10.2 Breast Cancer
11.10.3 Lung Cancer
11.10.4 Prostate Cancer
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Surgical Tumor Ablation Analysis and Forecast
12.1 Introduction
12.2 Latin America Surgical Tumor Ablation Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Surgical Tumor Ablation Market Size Forecast by Type
12.6.1 Radiofrequency Ablation
12.6.2 Microwave Ablation
12.6.3 Cryoablation
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Surgical Tumor Ablation Market Size Forecast by Applications
12.10.1 Liver Cancer
12.10.2 Breast Cancer
12.10.3 Lung Cancer
12.10.4 Prostate Cancer
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Surgical Tumor Ablation Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Surgical Tumor Ablation Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Surgical Tumor Ablation Market Size Forecast by Type
13.6.1 Radiofrequency Ablation
13.6.2 Microwave Ablation
13.6.3 Cryoablation
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Surgical Tumor Ablation Market Size Forecast by Applications
13.10.1 Liver Cancer
13.10.2 Breast Cancer
13.10.3 Lung Cancer
13.10.4 Prostate Cancer
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Surgical Tumor Ablation Market: Competitive Dashboard
14.2 Global Surgical Tumor Ablation Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Galil Medical
14.3.2 Misonix
14.3.3 HealthTronics
14.3.4 AngioDynamics
14.3.5 Medtronic
14.3.6 Boston Scientific Corporation
14.3.7 Medtronic
14.3.8 SonaCare Medical
14.3.9 EDAP TMS
14.3.10 NeuWave Medical
